ArticleClinical epidemiology2018

Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease.

Riccardo Di Domenicantonio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.